Diana Stindt
Overview
Explore the profile of Diana Stindt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
74
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Borden Jr L, Clark P, Lovato J, Craig Hall M, Stindt D, Harmon M, et al.
Cancer
. 2006 Aug;
107(5):1093-100.
PMID: 16888761
Background: Ultimately, patients with metastatic prostate cancer progress on androgen ablation therapy. The investigation of new chemotherapeutic regimens for the treatment of androgen-independent prostate cancer (AIPC) is essential. The authors...
3.
Clark P, Craig Hall M, Borden Jr L, Miller A, Hu J, Lee W, et al.
Urology
. 2006 Jun;
67(6):1257-61.
PMID: 16765186
Objectives: To report a prospective trial of lycopene supplementation in biochemically relapsed prostate cancer. Methods: A total of 36 men with biochemically relapsed prostate cancer were enrolled in a dose-escalating,...
4.
Schwartz G, Craig Hall M, Stindt D, Patton S, Lovato J, Torti F
Clin Cancer Res
. 2005 Dec;
11(24 Pt 1):8680-5.
PMID: 16361554
Purpose: We assessed the safety and efficacy of the vitamin D analogue, 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol), in patients with androgen-independent prostate cancer. Experimental Design: Patients received paricalcitol i.v. three times per...
5.
Clark P, Craig Hall M, Miller A, Ridenhour K, Stindt D, Lovato J, et al.
Urology
. 2004 Jun;
63(6):1061-5.
PMID: 15183950
Objectives: To present the results of a Phase II trial of thalidomide and interferon-alpha in renal cell carcinoma. Methods: Patients with metastatic clear cell renal cell carcinoma and no prior...